Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials.

Introduce

Cryptocurrency is an unregulated digital currency and is only available in electronic form. It can only be stored and traded through designated computer or software applications, mobile apps, or through a dedicated digital wallet. Transactions that happen on the internet are through dedicated and secure networks. Virtual currencies are considered a subset of the digital currency conglomerate, which also includes cryptocurrencies that exist in the blockchain network. In the future, one can trade home ownership as easily as sending money from one person to another. Many entities will need to own cryptocurrencies to take advantage of what Blockchain technology offers.

And securing and managing these crypto assets can be quite difficult, with mistakes often becoming terminal. Today tools available on the market designed for technically savvy individuals or developers, companies and businesses are still quite difficult to manage their cryptocurrencies effectively and safe. Hup Life has since added an interface layer to make blockchain technology more accessible, helping companies manage crypto files efficiently and becoming the only product companies need to run operations. electronic money movement.

What is Triall?

Triall is the world’s first organization to implement blockchain in clinical trials. They have a working commercial product, existing clients, and a revenue-generating business that they’ve been building since 2017. Combined, Triall’s team has managed 100+ clinical trials, established successful companies (both in the healthcare and software industries), and published 250+ academic papers about medical innovation, including in top-tier journals such as Science and Nature. Triall is motivated to bring the power of blockchain technology to its industry domain. Supported by an international partner and customer network, they build towards the world’s first blockchain-enabled digital ecosystem for clinical trial professionals. Triall is integrated with well-established public blockchains, and $TRL is an ERC20 token.

The Triall project will release a range of blockchain-integrated clinical trial software applications, collaborating closely with medical researchers that are working in clinical trials on a daily basis. Each of these software applications targets specific, industry-validated pain points. The common objective of these software applications is to improve data integrity, auditability, and task efficiency in modern-day medical research processes. The first product by Triall, Verial eTMF, has been used by clinical trials since 2019. It is a blockchain-integrated clinical trial document management solution, which enables users to generate verifiable proof of the integrity of their clinical trial documents. This is a unique feature, specifically designed to mitigate the growing number of data integrity issues reported in clinical trials. The launch of Verial eTMF was credited as the world’s first application of blockchain technology in a real-world clinical trial. For more information and features about this revolutionary medical blockchain project, you may visit the Triall official website.

The 7 growth drivers of the Triall ecosystem:

Token value drivers: the token economics of $TRL are designed to limit supply and drive demand. The circulating token supply is limited through various token lock-up mechanics such as staking rewards, memberships, and vesting schedules. Moreover, we introduce a token burn policy to stimulate a deflationary trend where the total supply is expected to decrease over time. The token demand is driven by increasing token utility and adoption through the various growth drivers explained below.

Scalable business model & infrastructure: our tokenized Software-as-a-Service (SaaS)-business model, API-driven infrastructure, and Agile development approach enable fast time-to-market, easy maintenance, and rapid scaling.

Multi-sided platform dynamics: our ‘ecosystem approach’, where we connect, rather than compete with existing solutions (turning competitors into collaborators), will lead to synergistic network effects where we can tap into the business networks of entities that join our initiative.

International value network: we have an international partner network and global advisory board consisting of industry experts and Key Opinion Leaders (KOLs) that provide us with access to clients, expertise, and know-how all across the globe.

Customer-centric product development: we aim to continuously optimize the product-market fit of our solutions by frequently evaluating user satisfaction on a feature-specific level, enabling us to identify areas of improvement and thereby drive adoption.

Global business development: We are a project with global ambitions. Building on our existing network within the EU & US, we will gradually expand our sales to other geographies (APAC, Africa). Our cloud-based technology can easily be rolled out in other regions and we have an existing network of ambassadors and advisors across the globe that can serve as a steppingstone for expanding our sales channels to these geographies.

Double-digit growth market: the market for clinical trial software is rapidly growing at an estimated 13.8% CAGR, which is likely to be even higher due to the effects of the pandemic .

Conclusion

The market for crypto projects is developing and every day the community receives new crypto platforms, but not all of them are workable and carry value both for the community itself and for the entire crypto industry. At Triall, they are now laying the groundwork for this technology to be readily integrable in real-world clinical trials globally, and that makes me extremely proud. I want to thank the blockchain pioneers before us, that have provided us with the tools and infrastructure to realize the long-sought-after real-world use cases that we are developing with Triall.

Triall Social Channels

Website: https://www.triall.io/
Twitter: https://twitter.com/triallofficial
Facebook: https://www.facebook.com/triallofficial/
Linkedin: https://linkedin.com/company/triallofficial
Telegram: https://t.me/triallcommunity

Author

louisadayvin

A sponsored article written for a bounty reward.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Louisa Dayvin

Louisa Dayvin

Wantiing your love to come into me !!!